« Back to Glossary Index

CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene-editing technology. CRISPR was invented in 2012 by Jennifer Doudna and Emmanuelle Charpentier and won them the Nobel Prize in Chemistry in 2020; the technology allows for precise DNA editing within living organisms and works by utilizing the Cas9 protein by being programmed to target specific DNA sequences to make exact cuts in DNA. CRISPR has been used to treat medical conditions, such as sickle cell anemia and certain forms of inherited blindness.

The potential application of CRISPR in lifespan extension has garnered significant attention within the longevity research community. Some researchers believe that CRISPR could be used to modify genes associated with aging, such as those involved in cellular senescence or DNA damage repair. This could lead to extended lifespans and improved health in later life. While the timeline for these advancements remains uncertain, expecting significant progress within the next few decades is not unreasonable. However, the viability of CRISPR for lifespan extension will ultimately depend on our understanding of the underlying mechanisms of aging and the ethical considerations surrounding gene editing in humans.

Here is a short explainer video from Youtube on CRISPR gene editing.

Pros of CRISPR for longevity extension:

  • Precise and targeted gene editing.
  • Potential to treat age-related diseases and conditions.
  • Possibility to delay or reverse certain aspects of aging.

Cons of CRISPR for longevity extension:

  • Ethical concerns surrounding genetic manipulation.
  • Possibility of unintended consequences or side effects.
  • Uncertainty regarding the long-term effects of gene editing on humans.

Overall, CRISPR holds significant promise for longevity research and lifespan extension. However, further research is needed to understand this groundbreaking technology’s potential benefits and risks fully.

« Back to Glossary Index